302 related articles for article (PubMed ID: 10811846)
1. Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.
Fushimi T; Kojima A; Moore MA; Crystal RG
J Clin Invest; 2000 May; 105(10):1383-93. PubMed ID: 10811846
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
Fushimi T; O'Connor TP; Crystal RG
Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
[TBL] [Abstract][Full Text] [Related]
3. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine.
Iwasaki A; Kelsall BL
J Exp Med; 2000 Apr; 191(8):1381-94. PubMed ID: 10770804
[TBL] [Abstract][Full Text] [Related]
4. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.
Furumoto K; Soares L; Engleman EG; Merad M
J Clin Invest; 2004 Mar; 113(5):774-83. PubMed ID: 14991076
[TBL] [Abstract][Full Text] [Related]
5. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity.
Bonnotte B; Crittenden M; Larmonier N; Gough M; Vile RG
J Immunol; 2004 Oct; 173(8):4929-35. PubMed ID: 15470034
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
[TBL] [Abstract][Full Text] [Related]
7. Administration of MIP-3alpha gene to the tumor following radiation therapy boosts anti-tumor immunity in a murine model of lung carcinoma.
Zhu B; Zou L; Cheng X; Lin Z; Duan Y; Wu Y; Zhou F; Chen Z
Immunol Lett; 2006 Mar; 103(2):101-7. PubMed ID: 16257060
[TBL] [Abstract][Full Text] [Related]
8. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity.
Crittenden M; Gough M; Harrington K; Olivier K; Thompson J; Vile RG
Cancer Res; 2003 Sep; 63(17):5505-12. PubMed ID: 14500387
[TBL] [Abstract][Full Text] [Related]
9. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
Dieu MC; Vanbervliet B; Vicari A; Bridon JM; Oldham E; Aït-Yahia S; Brière F; Zlotnik A; Lebecque S; Caux C
J Exp Med; 1998 Jul; 188(2):373-86. PubMed ID: 9670049
[TBL] [Abstract][Full Text] [Related]
10. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver.
Shimizu Y; Murata H; Kashii Y; Hirano K; Kunitani H; Higuchi K; Watanabe A
Hepatology; 2001 Aug; 34(2):311-9. PubMed ID: 11481616
[TBL] [Abstract][Full Text] [Related]
11. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Kikuchi T; Miyazawa N; Moore MA; Crystal RG
Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
[TBL] [Abstract][Full Text] [Related]
12. Tumour regression induced by co-administration of MIP-3α and CpG in an experimental model of colon carcinoma.
Arab S; Mojarrad M; Motamedi M; Mirzaei R; Modarressi MH; Hadjati J
Scand J Immunol; 2013 Jul; 78(1):28-34. PubMed ID: 23672351
[TBL] [Abstract][Full Text] [Related]
13. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity.
Izadpanah A; Dwinell MB; Eckmann L; Varki NM; Kagnoff MF
Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G710-9. PubMed ID: 11254498
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19.
Scapini P; Laudanna C; Pinardi C; Allavena P; Mantovani A; Sozzani S; Cassatella MA
Eur J Immunol; 2001 Jul; 31(7):1981-8. PubMed ID: 11449350
[TBL] [Abstract][Full Text] [Related]
15. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter.
Reibman J; Hsu Y; Chen LC; Bleck B; Gordon T
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):648-54. PubMed ID: 12760962
[TBL] [Abstract][Full Text] [Related]
16. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
Kikuchi T; Moore MA; Crystal RG
Blood; 2000 Jul; 96(1):91-9. PubMed ID: 10891436
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.
Zhang W; Chen Z; Li F; Kamencic H; Juurlink B; Gordon JR; Xiang J
Immunology; 2003 Feb; 108(2):177-88. PubMed ID: 12562326
[TBL] [Abstract][Full Text] [Related]
19. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.
Dieu-Nosjean MC; Massacrier C; Homey B; Vanbervliet B; Pin JJ; Vicari A; Lebecque S; Dezutter-Dambuyant C; Schmitt D; Zlotnik A; Caux C
J Exp Med; 2000 Sep; 192(5):705-18. PubMed ID: 10974036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
